RISK FACTORS AND HYSTEROSCOPIC RESULTS FOR INSUFFICIENT TISSUE FROM ENDOMETRIAL BIOPSY

Year 2020, , 204 - 211, 23.08.2020

Şükrü Yıldız , İsmail Alay

https://doi.org/10.37696/nkmj.667710

Abstract

Abstract
Aim: This study aimed to evaluate the maternal and neonatal outcomes of placenta previa cases managed in our hospital.
Materials and Methods: The records of 107 placenta previa cases delivered between 2011 and 2016 were retrospectively reviewed. Age, gravida, parity, red blood cell (RBC)-fresh frozen plasma (FFP) transfusion necessity, the gestational week at birth, birth weight, 1st and 5th minute Apgar score, the number of previous cesarean sections, requiring additional surgical intervention (internal iliac artery ligation [IIAL], peripartum hysterectomy) and maternal complications were examined.
Results: RBC-FFP transfusion and IIAL rates were significantly higher in complete placenta previa cases than the partial placenta previa cases. RBC-TDP transfusion, IIAL and peripartum hysterectomy rates were significantly higher in placenta accreata spectrum (PAS) cases compared to those cases with normal placental invasion. Prematurity risk increased in all placenta previa subgroups.
Conclusion: Pregnancy complicated by placenta previa increases the risk of adverse maternal and neonatal outcomes, especially if there is concurrent placental invasion anomaly.
Keywords: Placenta praevia, placenta accreata, postpartum hemorrhage.

Keywords

placenta accreata, Placenta praevia, postpartum hemorrhage

Endometriyal biyopsi sonrası yetersiz doku tanısının olası risk faktörleri ve histeroskopik sonuçları

Abstract

Giriş: Bu çalışmanın amacı yetersiz endometriyal doku tanısında rol oynayabilecek risk faktörlerini belirlemek ve bu hastaların ofis histeroskopi bulgularını değerlendirmektir.
Materyal ve Metod: Ağustos 2018-Kasım 2019 tarihleri arasında Bakırköy Dr. Sadi Konuk Eğitim ve Araştırma hastanesinde yetersiz endometrial doku tanılı hastaların klinik verileri ve sonuçları retrospektif olarak incelendi.
Bulgular: Çalışma için değerlendirilen süre boyunca 1560 hastaya endometrial biyopsi işlemleri uygulandı. 81 hastanın (% 5.2) patoloji raporu yetersiz endometriyal doku olarak değerlendirildi. Çalışma kriterleri eşliğinde 64 hastanın sonuçları analiz edildi. Çalışmadaki hastaların yaş ortalaması 52,1 (dağılım = 32-78) idi. Histeroskopi uygulanan 64 hastanın sonuçları; normal histeroskopik bulgular (22 hasta; % 34), endometriyal polip (18 hasta; % 28), submuköz miyom görünümü (6 hasta; % 10) ve atrofik endometriyal görünüm (18 hasta; % 28) olarak değerlendirildi.
Sonuç: 60 yaşın üzerindeki postmenopozal olgularda ve büyük çaplı myomu olan hastalarda yetersiz endometriyal doku tanısının daha sık tespit edebileceğine dikkat çekmekteyiz. Ek olarak, histeroskopinin yetersiz endometriyal doku tanılı hastalarda uygun tanı için klinisyene rehberlik edebileceğini vurgulamaktayız.

Keywords

Endometriyal biyopsi, Histeroskopi, Yetersiz endometriyal değerlendirme

References

• References 1. Berek JS, Hacker NF. Berek and Hacker’s Gynecologic Oncology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.
• 2. Chambers JT, Chambers SK. Endometrial sampling: When? Where? Why? With what? Clin Obstet Gynecol. 1992;35(1):28–39.
• 3. Shams G. Comparison of pipelle de cornier with conventional dilatation and curettage in terms of patients' acceptability. J Postgrad Med Inst (Peshawar-Pakistan) 2012;26:418–21.
• 4. Gordon SJ, Westgate J. The incidence and management of failed pipelle sampling in a general outpatient clinic. Aust N Z J Obstet Gynaecol 1999;39:115–8.
• 5. Sierecki AR, Gudipudi DK, Montemarano N, et al. Compar- ison of endometrial aspiration biopsy techniques: specimen adequacy. J Reprod Med 2008;53:760–4.
• 6. Tanriverdi HA, Barut A, Gün BD, et al. Is pipelle biopsy really adequate for diagnosing endometrial disease? Med Sci Monit 2004;10:CR271–4.
• 7. Williams AR, Brechin S, Porter AJ, et al. Factors affecting adequacy of pipelle and Tao Brush endometrial sampling. BJOG 2008;115:1028–36. 

• 8. Ronghe R, Gaudoin M. Women with recurrent postmenopausal bleeding should be re-investigated but are not more likely to have endometrial cancer. Menopause Int 2010;16:9–11. 

• 9. Larson DM, Broste SK. Histopathologic adequacy of office endometrial biopsies taken with the Z-sampler and Novak curette in premenopausal and postmenopausal women. J Reprod Med 1994;39:300–3. 

• 10. Bettocchi S, Ceci O, Di Venere R et al. Advanced operative office hysteroscopy without anesthesia: analysis of 501 cases treated with a 5 fr. bipolar electrode. Hum Reprod. 2002;17:2435-8. 

• 11. Harmanli OH, Shunmugham S, Shen T, Houck KL, Chatwani AJ. The negative predictive value of ‘’in adequate’’ endometrial biopsy in diagnosing endometrial neoplasia. J Gynecol Surg 2004;20:13-6.
• 12. Gordon SJ, Westgate J. The incidence and management of failed pipelle sampling in a general outpatient clinic. Aust N Z J Obstet Gynaecol 1999;39:115-8.
• 13. Clark TJ, Mann CH, Shah N, Song F, Khan KS, Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic qualitative review. BJOG 2002;109:313-21.
• 14. Bakour SH, Khan KS, Gupta JK. Controlled analysis of factors associated with insufficient sample on outpatient endometrial biopsy. BJOG. 2000;107(10):1312–1314.
• 15. van Doorn HC, Opmeer BC, Burger CW, et al. Inadequate office endometrial sample requires further evaluation in women with post-menopausal bleeding and abnormal ultrasound results. Int J Gynaecol Obstet. 2007;99(2):100–104.
• 16. Xie B, Qian C, Yang B, et al. Risk Factors for Unsuccessful Office- Based Endometrial Biopsy: A Comparative Study of Office-Based Endometrial Biopsy (Pipelle) and Diagnostic Dilation and Curettage. J Minim Invasive Gynecol. 2018;25(4):724–729.
• 17. Visser NC, Breijer MC, Herman MC, et al. Factors attributing to the failure of endometrial sampling in women with postmenopausal bleeding. Acta Obstet Gynecol Scand. 2013;92(10):1216–1222.
• 18. Kandil D, Yang X, Stockl T, Liu Y. Clinical outcomes of patients with insufficient sample from endometrial biopsy or curettage. Int J Gynecol Pathol. 2014;33(5):500–506.
• 19. Adambekov S, Goughnour SL, Mansuria S et al. Patient and provider factors associated with endometrial Pipelle sampling failure. Gynecol Oncol. 2017;144(2):324–328.
• 20. Cancer Australia. Abnormal vaginal bleeding in pre- and peri-menopausal women: a diagnostic guide for general practitioners and gynaecologists. Surry Hills: Cancer Australia;2011.
• 21. SOGC clinical practice guideline No. 86. Diagnosis of endometrial cancer in women with abnormal vaginal bleeding. J Soc Obstet Gynaecol Can 2000;22:102-4.
• 22. Youssif SN, McMillian DL. Outpatient endometrial biopsy: the pipelle. Br J Hosp Med 1995;54(5):198-201.
• 23. Aue-Aungkul A, Kleebkaow P, Kietpeerakool C. Incidence and risk factors for insufficient endometrial tissue for endometrial sampling. Int J Womens Health 2018;10:453-457.
• 24. Yarandi F, Izadi-Mood N, Eftekhar Z, Shojaei H, Sarmadi S. Diagnostic accuracy of dilatation and curettage for abnormal uterine bleeding. J Obstet Gynaecol Res 2010;36:1049-52.